A comprehensive fracture prevention strategy in older adults: The European union geriatric medicine society (EUGMS) statement

Autor: Alvarez, M.N., Annweiler, C., Bernard, P.-L., Beswetherick, N., Bischoff-Ferrari, H.A., Bloch, F., Boddaert, J., Bonnefoy, M., Bousson, V., Bourdel-Marchasson, I., Capisizu, A., Che, H., Clara, J.G., Combe, B., Delignieres, D., Eklund, P., Emmelot-Vonk, M., Freiberger, E., Gauvain, J.-B., Goswami, N., Guldemond, N., Herrero, Á.C., Joël, M.-E., Jónsdóttir, A.B., Kemoun, G., Kiss, I., Kolk, H., Kowalski, M.L., Krajcík, Š., Kutsal, Y.G., Lauretani, F., Macijauskienė, J., Mellingsæter, M., Morel, J., Mourey, F., Nourashemi, F., Nyakas, C., Puisieux, F., Rambourg, P., Ramírez, A.G., Rapp, K., Rolland, Y., Ryg, J., Sahota, O., Snoeijs, S., Stephan, Y., Thomas, E., Todd, C., Treml, J., Adachi, R., Agnusdei, D., Body, J.-J., Breuil, V., Bruyère, O., Burckardt, P., Cannata-Andia, J.B., Carey, J., Chan, D.-C., Chapuis, L., Chevalley, T., Cohen-Solal, M., Dawson-Hughes, B., Dennison, E.M., Devogelaer, J.-P., Fardellone, P., Féron, J.-M., Perez, A.D., Felsenberg, D., Glueer, C., Harvey, N., Hiligsman, M., Javaid, M.K., Jörgensen, N.R., Kendler, D., Kraenzlin, M., Laroche, M., Legrand, E., Leslie, W.D., Lespessailles, E., Lewiecki, E.M., Nakamura, T., Papaioannou, A., Roux, C., Silverman, S., Henriquez, M.S., Thomas, T., Vasikaran, S., Watts, N.B., Weryha, G., Blain, H., Masud, T., Dargent-Molina, P., Martin, F.C., Rosendahl, E., van der Velde, N., Bousquet, J., Benetos, A., Cooper, C., Kanis, J.A., Reginster, J.Y., Rizzoli, R., Cortet, B., Barbagallo, M., Dreinhöfer, K., Vellas, B., Maggi, S., Strandberg, T.

Publikováno v: In European Geriatric Medicine December 2016 7(6):519-525

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

Autor: Diez-Perez, A, Naylor, KE, Abrahamsen, B, Agnusdei, D, Brandi, ML, Cooper, C, Dennison, E, Eriksen, EF, Gold, DT, Guanabens, N, Hadji, P, Hiligsmann, M, Horne, R, Josse, R, Kanis, JA, Obermayer-Pietsch, B, Prieto-Alhambra, D, Reginster, JY, Rizzoli, R, Silverman, S, Zillikens, M.C., Eastell, R, Int Osteoporosis, F, European Calcif Tissue, S

Publikováno v: Diez-Perez, A, Naylor, K E, Abrahamsen, B, Agnusdei, D, Brandi, M L, Cooper, C, Dennison, EM, Eriksen, E F, Gold, D T, Guañabens, N, Hadji, P, Hiligsmann, M, Horne, R, Josse, R, Kanis, J A, Obermayer-Pietsch, B, Prieto-Alhambra, D, Reginster, J-Y, Rizzoli, R, Silverman, S, Zillikens, M C & Eastell, R 2017, ' International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates ', Osteoporosis International, vol. 28, no. 3, pp. 767-774 . https://doi.org/10.1007/s00198-017-3906-6
Osteoporosis International, 28(3), 767-774. Springer-Verlag London Ltd.
Osteoporosis International, Vol. 28, No 3 (2017) pp. 767-774
Osteoporosis International, 28(3), 767-774. Springer London

Adherence to oral bisphosphonates is low. A screening strategy is proposed based on the response of biochemical markers of bone turnover after 3 months of therapy. If no change is observed, the clinician should reassess the adherence to the treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::195bbbd5a5d21edf1fb15bc6d154af0a
https://europepmc.org/articles/PMC5302161/

Osteoporosis treatment and fracture incidence: the ICARO longitudinal study

Autor: Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Silvestri S, Agnusdei D, Gentilella R, Nuti R, ICARO Study Group, DEL PUENTE, ANTONIO

Publikováno v: Osteoporosis International. 19:1219-1223

None of the available osteoporosis therapies completely abolish the risk of fracture. Among 862 patients on treatment with antiresorptive agents (alendronate, risedronate, and raloxifene) for1 year a fragility fracture was observed in 9.5%/year. This

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6077b8c65d46b31052bffc2157ed3506
https://doi.org/10.1007/s00198-008-0566-6

Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis

Autor: Lips, P, Cooper, C, Agnusdei, D, Caulin, F, Egger, P, Johnell, O, Kanis, JA, Kellingray, S, Leplege, A, Liberman, UA, McCloskey, E, Minne, H, Reeve, J, Reginster, JY, Scholz, M, Todd, C, de Vernejoul, MC, Wiklund, I

Vertebral fractures may be minor or lead to pain, decreased physical function, immobility, social isolation and depression, which together contribute to quality of life. A Working Party of the European Foundation for Osteoporosis has developed a spec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3d176a83b0ec45736117247ab4c24108
https://ora.ox.ac.uk/objects/uuid:63ddec32-7ee2-4f07-96d1-3ede94c29bc0

Taxonomy of rare genetic metabolic bone disorders (vol 26, pg 2529, 2015)

Autor: Masi, L., Agnusdei, D., Bilezikian, J., Chappard, D., Chapurlat, R., Cianferotti, L., Devolgelaer, J.P., Maghraoui, A. el, Ferrari, S., Javaid, K., Kaufman, J.M., Liberman, U.A., Lyritis, G., Miller, P., Napoli, N., Roldan, E., Papapoulos, S., Watts, N.B., Brandi, M.L.

Publikováno v: Osteoporosis International, 26(11), 2717-2718

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7e709907a13888ac80ceaa2309a99650
http://hdl.handle.net/1887/107863